| Source of EVs | Protein | Function | Reference |
| Human bone marrow-derived MSCs | CD13, CD29, CD44, CD73, CD105, CD81, CD63, CD90, CD9 | Surface antigen | [39–41] | Human bone marrow-derived MSCs | PDGFRB, EGFR, TGFBI, IGF2R | MSCs self-renewal | [39] | Human bone marrow-derived MSCs | CTNNBI, RAC1, RAC2, CHP, PRKCB, PPP2RIA, CAMK2D, PRKACA, CAMK2G | MSCs self-renewal and differentiation, Wnt signaling pathway | [39] | Human bone marrow-derived MSCs | PPP2RIA, MAPK1, USP9X, COL1A2, CD105, ENG | MSCs differentiation, TGFβ signaling pathway | [39] | Human bone marrow-derived MSCs | FLNA, HSPAB, CACNA2D1, CHP, FLNC, PDGFRB, RAP1B, RRAS2, MAP4K4, EGFR, RRAS, GNG12, RAC1, HSPAIA, CDC42, RAC2, NRAS, MAPKl, CD81, FLNB, HSPBl, PRKCB, PRKACA, RAP1A, GNAI2, CAVI, PRDX2, PPP2RIA, SOD1, ITGA1, LPAR1 | MSCs differentiation, MAPK signaling pathway | [39] | Human bone marrow-derived MSCs | ILK, FABP5, ACSL4 | MSCs differentiation, PPAR signaling pathway | [39] | Human bone marrow-derived MSCs | ENG, USP9X | MSCs differentiation, BMP signaling pathway | [39] | Human adipose tissue-derived MSCs | Neprilysin | Degrade intracellular and extracellular β-amyloid peptide in neuroblastoma cell lines | [42] | Human bone marrow-derived MSCs | TIA, TIAR, HuR | T cell internal antigen | [43] | Human bone marrow-derived MSCs | Stau1, Stau2 | Involved in the transport and stability of mRNA | [43] | Human bone marrow-derived MSCs | Ago2 | Involved in the miRNA transport and processing | [43] | Human umbilical cord-derived MSCs | Wnt4 | Enhance the proliferation and migration | [43] | Human umbilical cord-derived MSCs | Angiogenin, IL-6, bFGF, UPAR, VEGF, MCP-1, VEGF R2, IGF-I | Promote angiogenesis | [44, 45] |
|
|